covid-19 testing vaccine Coronavirus

Covid-19 testmakers dealt $38 billion blow by Pfizer’s vaccine

Reading now: 905
www.livemint.com

Covid-19 sent companies that have developed and sold tests to diagnose the condition spiraling, wiping out about $38 billion in market value across more than a dozen stocks.Concerns about the sustainability of profits for the testing-kit market erased about a third of Quidel Corp.’s value.

High-flying stocks including Hologic Inc. and Qiagen tumbled 8% or more, while competitors like Thermo Fisher Scientific Inc., Abbott Laboratories, and Danaher Corp.

shed billions in value as their stocks faded.Some industry watchers had been optimistic for the group’s resilience despite advancements for vaccines and therapies to combat the coronavirus.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA